welcome to oneGRAVESvoice- a positively charged Graves' disease and thyroid eye disease community.
- join today!
- log in
Prem Subramanian, MD, PhD
Department of Ophthalmology
University of Colorado School of Medicine
Anschutz Medical Campus
1675 Aurora Court, Mailstop F-731
Aurora, Colorado, United States
Prem S. Subramanian is the Professor of ophthalmology, neurology, and neurosurgery at University of Colorado School of Medicine Anschutz Medical Campus. He specializes in neuro-ophthalmology, with special interest in the treatment of thyroid eye disease, disorders that cause double-vision in adults, as well as orbital and skull base tumors. His clinical practice includes patients with all types of disorders of the optic nerve and orbit. He performs surgery for tumors of the orbit, thyroid exophthalmos, and strabismus.
Dr. Subramanian received his medical degree from Baylor College of Medicine, Houston, Texas followed by residency in ophthalmology from Walter Reed Army Medical Center, Washington, DC and fellowship in neuro-ophthalmology from Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. He has an experience in treating conditions like cranial nerve palsies, double vision, intracranial hypertension, multiple sclerosis, ophthalmology, optic nerve disease, orbital tumors, pseudotumor cerebri, skull base tumors, strabismus, thyroid eye disease, and venous sinus stenosis. His research interests include optic nerve regeneration, traumatic brain injury, and effects of diplopia on quality of life.
James A. Katowitz, MDJames A. Katowitz, MD, is an attending s...
Prospectively Recorded and MedDRA-Coded Safety Data of Intravenous Methylprednisolone Therapy in Graves’ Orbit...Context: Safety of intravenous (IV) ste...
Nicholas Robert Mahoney, MDNicholas Robert Mahoney is an Associate ...
Thyroid Eye Disease: The Battle of the Bulge, Part Ihttps://www.youtube.com/watch?v=L3fReHgz...
Clinical Study Data Highlighting the Impact of Teprotumumab in Patients With Active Thyroid Eye Disease to Be Presen...Horizon Therapeutics plc today announced...
Recent Developments in Graves’ OphthalmopathyRecent Developments in Graves' ophthalmo...
“TED Today” Episode 1https://www.facebook.com/ThyroidEyes/vid...